TH1501006213A - Dosage form of progesterone receptor antagonist - Google Patents

Dosage form of progesterone receptor antagonist

Info

Publication number
TH1501006213A
TH1501006213A TH1501006213A TH1501006213A TH1501006213A TH 1501006213 A TH1501006213 A TH 1501006213A TH 1501006213 A TH1501006213 A TH 1501006213A TH 1501006213 A TH1501006213 A TH 1501006213A TH 1501006213 A TH1501006213 A TH 1501006213A
Authority
TH
Thailand
Prior art keywords
dosage form
receptor antagonist
progesterone receptor
progesterone
antagonist
Prior art date
Application number
TH1501006213A
Other languages
Thai (th)
Other versions
TH163150B (en
TH163150A (en
Inventor
บาร์บาร่าชุทเวอ มอสเกา มาร์คัส ฮิลเลิร์ตไคเซอร์ แอนเดรียส ชุทต์
Original Assignee
เบเยอร์ ฟาร์มา อัคเตียนเกเซลล์ชาฟท์
Filing date
Publication date
Application filed by เบเยอร์ ฟาร์มา อัคเตียนเกเซลล์ชาฟท์ filed Critical เบเยอร์ ฟาร์มา อัคเตียนเกเซลล์ชาฟท์
Publication of TH163150B publication Critical patent/TH163150B/en
Publication of TH1501006213A publication Critical patent/TH1501006213A/en
Publication of TH163150A publication Critical patent/TH163150A/en

Links

TH1501006213A 2014-04-09 Dosage form of progesterone receptor anesthesia TH163150A (en)

Publications (3)

Publication Number Publication Date
TH163150B TH163150B (en) 2017-06-08
TH1501006213A true TH1501006213A (en) 2017-06-08
TH163150A TH163150A (en) 2017-06-08

Family

ID=

Similar Documents

Publication Publication Date Title
IL287437A (en) Solid dosage forms of palbociclib
DK3628687T3 (en) CHIMARY BCMA ANTIGEN RECEPTORS
DK3597663T3 (en) CHIMARY ANTIGEN RECEPTORS OF ANTI-CD70
DK3157508T3 (en) FIXED ORAL DOSAGE FORM OF LIPOPHILE COMPOUNDS
DK3089741T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING AZD9291
DK3143037T3 (en) ALPHA4BETA7-INTEGRIN-THIOETHER-PEPTIDE ANTAGONISTS
DK3272338T3 (en) ORAL DOSAGE FORM OF KETAMIN
DK3212637T3 (en) DOPAMIN-D3 RECEPTOR ANTAGONIST COMPOUNDS
MA41314A (en) DOSAGE REGIME FOR ANTAGONISTS OF MADCAM
DK3199161T3 (en) Pharmaceutical preparation
DK3126791T3 (en) DOSAGE DEVICE
DK3334721T3 (en) CGRP RECEPTOR ANTAGONISTS
DK3191085T3 (en) ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS
HRP20190141T1 (en) Progesterone receptor antagonist dosage form
EA202190993A3 (en) C-19 STEROIDS FOR INHIBITING NEOVASCULARIZATION
DK3089740T3 (en) PHARMACEUTICAL COMPOSITION
TH1501006213A (en) Dosage form of progesterone receptor antagonist
TH1601001484A (en) Formulation for CGRP Receptor Antagonist
TH1601003393A (en) Pharmaceutical dosage form
TH1701001501A (en) bowl feeder
UA31316S (en) SPREADING BAG FOR CEMENT
TH1501005346A (en) Pharmaceutical composition of S-ketamine hydrochloride
TH1601000893A (en) Receptor amide derivatives Antagonist of lysophosphatidic acid
CU20140011S4 (en) SET OF COMBINED CHAIRS
TH1601000020A (en) Preparation of ethanol from lignocellulosic materials